Search research articles
Contact Us
Filters
Showing results (111-120 of 138) with videos related to
Page
of 14
Sort By:
BMC Gastroenterology
|
June 13, 2021
Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan
Yu-Ting Huang, Yung-Yu Hsieh, Wei-Ming Chen, et al.
Cancers
|
August 7, 2021
A Yes-Associated Protein (YAP) and Insulin-Like Growth Factor 1 Receptor (IGF-1R) Signaling Loop Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
Mai-Huong T Ngo, Sue-Wei Peng, Yung-Che Kuo, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
January 9, 2024
Dual strategy involving hospital-based study and community-based screening to eliminate hepatitis C in remote areas
Chien-Hung Chen, Nien-Tzu Hsu, I-Chun Chen, et al.
Journal of Gastroenterology and Hepatology
|
May 12, 2021
Pangenotypic direct-acting antiviral agents for mixed genotype hepatitis C infection: A real-world effectiveness analysis
Yuan-Jie Ding, Chung-Kuang Lu, Wei-Ming Chen, et al.
Plos One
|
December 18, 2015
TGF-βI Regulates Cell Migration through Pluripotent Transcription Factor OCT4 in Endometriosis
Heng-Kien Au, Jui-Hung Chang, Yu-Chih Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
September 8, 2020
Usefulness of quantitative hepatitis B surface antigen testing in hepatitis B community-based screening
Kao-Chi Chang, Chih-Yi Lee, Te-Sheng Chang, et al.
Journal of Biomedical Science
|
June 16, 2014
Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells
Yung-Yu Hsieh, Chien-Heng Shen, Wen-Shih Huang, et al.
Plos One
|
August 18, 2022
Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world setting
Yung-Hsin Lu, Chung-Kuang Lu, Chun-Hsien Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2015
Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression
Te-Sheng Chang, Yu-Chih Wu, Ching-Chi Chi, et al.
Scientific Reports
|
June 30, 2021
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan
Kao-Chi Chang, Shui-Yi Tung, Kuo-Liang Wei, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 138) with videos related to
Sort By:
Page
of 14
BMC Gastroenterology
|
June 13, 2021
Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan
Yu-Ting Huang, Yung-Yu Hsieh, Wei-Ming Chen, et al.
Cancers
|
August 7, 2021
A Yes-Associated Protein (YAP) and Insulin-Like Growth Factor 1 Receptor (IGF-1R) Signaling Loop Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
Mai-Huong T Ngo, Sue-Wei Peng, Yung-Che Kuo, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
January 9, 2024
Dual strategy involving hospital-based study and community-based screening to eliminate hepatitis C in remote areas
Chien-Hung Chen, Nien-Tzu Hsu, I-Chun Chen, et al.
Journal of Gastroenterology and Hepatology
|
May 12, 2021
Pangenotypic direct-acting antiviral agents for mixed genotype hepatitis C infection: A real-world effectiveness analysis
Yuan-Jie Ding, Chung-Kuang Lu, Wei-Ming Chen, et al.
Plos One
|
December 18, 2015
TGF-βI Regulates Cell Migration through Pluripotent Transcription Factor OCT4 in Endometriosis
Heng-Kien Au, Jui-Hung Chang, Yu-Chih Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
September 8, 2020
Usefulness of quantitative hepatitis B surface antigen testing in hepatitis B community-based screening
Kao-Chi Chang, Chih-Yi Lee, Te-Sheng Chang, et al.
Journal of Biomedical Science
|
June 16, 2014
Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells
Yung-Yu Hsieh, Chien-Heng Shen, Wen-Shih Huang, et al.
Plos One
|
August 18, 2022
Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world setting
Yung-Hsin Lu, Chung-Kuang Lu, Chun-Hsien Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2015
Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression
Te-Sheng Chang, Yu-Chih Wu, Ching-Chi Chi, et al.
Scientific Reports
|
June 30, 2021
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan
Kao-Chi Chang, Shui-Yi Tung, Kuo-Liang Wei, et al.
Page
of 14